Keyphrases
2-year Follow-up
57%
Abdominal Obesity
23%
Adverse Effects
19%
Antipsychotic-induced Weight Gain
57%
Antipsychotics
100%
Benzodiazepines
57%
Cannabis
57%
Cardiovascular Risk
46%
Care Coordination
57%
Change in Weight
19%
Cigarette Smoking
23%
Confidence Interval
34%
Danish Population
23%
Denmark
23%
Dietary Habits
46%
Dietary Patterns
57%
Dose Reduction
57%
Drug Discontinuation
19%
Drug Switching
19%
Energy Intake
23%
Group-based
19%
Lifestyle Coaching
57%
Maintenance Group
19%
Maintenance Treatment
19%
Meta-analysis
57%
Monotherapy
38%
Nationwide Registers
57%
Negative Symptoms
34%
Partial Agonist
38%
Patients with Schizophrenia
13%
People with Schizophrenia
57%
People with Severe Mental Illness
57%
Physical Activity
69%
Physical Activity Level
46%
Polypharmacy
38%
Positive Symptoms
23%
Post-analysis
19%
Psychiatric Hospitalization
57%
Psychological Well-being
19%
Randomized Controlled Trial
19%
Register Study
57%
Schizophrenia
57%
Schizophrenia Spectrum Disorders
57%
Systematic Meta-analysis
57%
Treatment as Usual
57%
Uncontrolled Study
38%
Waist Circumference
57%
Weight Change
19%
Weight Gain
19%
Weight Loss
19%
Medicine and Dentistry
Abdominal Obesity
23%
Adverse Event
18%
Benzalkonium Chloride
11%
Caloric Intake
14%
Cardiorespiratory
11%
Cardiovascular Disease
37%
Cardiovascular Mortality
7%
Cardiovascular Risk
23%
Care Coordination
57%
Clinical Trial
11%
Dietary Habit
28%
Dietary Intake
7%
Dietary Pattern
57%
Disease
7%
Drug Therapy
14%
Eating Habit
7%
Food Frequency Questionnaire
7%
Global Assessment of Functioning
7%
Lifestyle Modification
7%
Lomustine
11%
Mental Disorder
7%
Mental Health Service
11%
Negative Syndrome
21%
Obesity
72%
Physical Activity
69%
Physical Activity Level
7%
Physical Inactivity
7%
Population
43%
Positive Syndrome
14%
Saturated Fatty Acid
7%
Schizophrenia Spectrum Disorder
44%
Severe Mental Illness
57%
Small-Angle Neutron Scattering
7%
Smoking
21%
Social Desirability
7%
Treatment Effect
11%